Subcutaneous sumatriptan for the treatment of postcraniotomy pain (SUPS trial): protocol for a randomised double-blinded placebo controlled trial

INTRODUCTION: Postcraniotomy pain protocols use opioids, which are considered suboptimal analgesia following this procedure. Multimodal analgesia components are sparse. Our null hypothesis states that sumatriptan is not different to placebo in addition to usual intravenous opioids, for the treatment...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMJ Open
Egile Nagusiak: Licina, Ana, Russell, Jeremy, Silvers, Andrew, Jin, Xin, Denny, Jason
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2019
Gaiak:
Anaesthesia
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6701595/
https://ncbi.nlm.nih.gov/pubmed/31427345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-032388
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak